

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.70199407 |
| 2 | complement activation, alternative pathway (GO:0006957) | 5.56146710 |
| 3 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.46528046 |
| 4 | immunoglobulin mediated immune response (GO:0016064) | 5.43895936 |
| 5 | response to peptidoglycan (GO:0032494) | 5.18652907 |
| 6 | positive regulation of cholesterol efflux (GO:0010875) | 5.08444733 |
| 7 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.88030533 |
| 8 | pinocytosis (GO:0006907) | 4.86650015 |
| 9 | negative regulation of B cell apoptotic process (GO:0002903) | 4.84380060 |
| 10 | cellular extravasation (GO:0045123) | 4.81020466 |
| 11 | positive regulation of sterol transport (GO:0032373) | 4.70906507 |
| 12 | positive regulation of cholesterol transport (GO:0032376) | 4.70906507 |
| 13 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.57690695 |
| 14 | negative regulation of granulocyte differentiation (GO:0030853) | 4.48868016 |
| 15 | regulation of complement activation (GO:0030449) | 4.39958491 |
| 16 | regulation of protein activation cascade (GO:2000257) | 4.36313679 |
| 17 | regulation of cholesterol storage (GO:0010885) | 4.27429826 |
| 18 | folic acid transport (GO:0015884) | 4.25311935 |
| 19 | macroautophagy (GO:0016236) | 4.23023825 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.21618177 |
| 21 | complement activation (GO:0006956) | 4.20113453 |
| 22 | glycosphingolipid catabolic process (GO:0046479) | 4.15412087 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.13146204 |
| 24 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.05220483 |
| 25 | regulation of B cell apoptotic process (GO:0002902) | 4.01377124 |
| 26 | germinal center formation (GO:0002467) | 3.92617127 |
| 27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.92037748 |
| 28 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89818699 |
| 29 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89818699 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.87351372 |
| 31 | amino sugar catabolic process (GO:0046348) | 3.83560948 |
| 32 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.82660823 |
| 33 | complement activation, classical pathway (GO:0006958) | 3.81826404 |
| 34 | regulation of macrophage chemotaxis (GO:0010758) | 3.81095310 |
| 35 | B cell mediated immunity (GO:0019724) | 3.78996364 |
| 36 | oligosaccharide catabolic process (GO:0009313) | 3.75356232 |
| 37 | glycolipid catabolic process (GO:0019377) | 3.71682886 |
| 38 | regulation of cholesterol homeostasis (GO:2000188) | 3.70596058 |
| 39 | T-helper 1 type immune response (GO:0042088) | 3.69924083 |
| 40 | basic amino acid transport (GO:0015802) | 3.69864198 |
| 41 | transcytosis (GO:0045056) | 3.64697445 |
| 42 | negative regulation of type 2 immune response (GO:0002829) | 3.61671033 |
| 43 | negative regulation of lipid storage (GO:0010888) | 3.60368020 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.59354674 |
| 45 | amyloid precursor protein catabolic process (GO:0042987) | 3.59076748 |
| 46 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.58846256 |
| 47 | lymphocyte chemotaxis (GO:0048247) | 3.52527458 |
| 48 | apoptotic cell clearance (GO:0043277) | 3.49582853 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.48758667 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 3.48758667 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.48450500 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.46526785 |
| 53 | N-acetylneuraminate metabolic process (GO:0006054) | 3.45932251 |
| 54 | negative regulation of digestive system process (GO:0060457) | 3.44860793 |
| 55 | protein activation cascade (GO:0072376) | 3.44734968 |
| 56 | mast cell degranulation (GO:0043303) | 3.44532907 |
| 57 | mast cell activation involved in immune response (GO:0002279) | 3.44532907 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41004457 |
| 59 | macrophage activation (GO:0042116) | 3.40401651 |
| 60 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.39997864 |
| 61 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.39973053 |
| 62 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.39234500 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 3.36279523 |
| 64 | mast cell activation (GO:0045576) | 3.36268030 |
| 65 | regulation of cholesterol efflux (GO:0010874) | 3.35068013 |
| 66 | ceramide catabolic process (GO:0046514) | 3.32382595 |
| 67 | regulation of memory T cell differentiation (GO:0043380) | 3.32184485 |
| 68 | monocyte chemotaxis (GO:0002548) | 3.30551828 |
| 69 | granulocyte activation (GO:0036230) | 3.29371521 |
| 70 | negative regulation of cell killing (GO:0031342) | 3.29369974 |
| 71 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.29369974 |
| 72 | phospholipid efflux (GO:0033700) | 3.28695629 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.27690477 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.27084327 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.25880905 |
| 76 | regulation of podosome assembly (GO:0071801) | 3.25751640 |
| 77 | detection of other organism (GO:0098543) | 3.24041859 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.23956592 |
| 79 | positive regulation of leukocyte degranulation (GO:0043302) | 3.23758524 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22956773 |
| 81 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22708656 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22658767 |
| 83 | detection of external biotic stimulus (GO:0098581) | 3.21316064 |
| 84 | alpha-linolenic acid metabolic process (GO:0036109) | 3.21149873 |
| 85 | respiratory burst (GO:0045730) | 3.21026817 |
| 86 | negative regulation of B cell mediated immunity (GO:0002713) | 3.20356862 |
| 87 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.20356862 |
| 88 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.19155506 |
| 89 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16653109 |
| 90 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15066380 |
| 91 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.13936976 |
| 92 | T cell migration (GO:0072678) | 3.13408160 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 3.12453057 |
| 94 | L-phenylalanine catabolic process (GO:0006559) | 3.11909320 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11909320 |
| 96 | urea metabolic process (GO:0019627) | 3.10853262 |
| 97 | urea cycle (GO:0000050) | 3.10853262 |
| 98 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.09827756 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 3.09197091 |
| 100 | eosinophil chemotaxis (GO:0048245) | 3.08839994 |
| 101 | aromatic amino acid family catabolic process (GO:0009074) | 3.06990535 |
| 102 | negative regulation of macroautophagy (GO:0016242) | 3.05789693 |
| 103 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.05302738 |
| 104 | protein carboxylation (GO:0018214) | 3.05214862 |
| 105 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.05214862 |
| 106 | lipoxygenase pathway (GO:0019372) | 3.05076411 |
| 107 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.03464390 |
| 108 | regulation of leukocyte degranulation (GO:0043300) | 3.02820118 |
| 109 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.02400972 |
| 110 | triglyceride homeostasis (GO:0070328) | 3.02353413 |
| 111 | acylglycerol homeostasis (GO:0055090) | 3.02353413 |
| 112 | myeloid dendritic cell differentiation (GO:0043011) | 3.01702050 |
| 113 | myeloid cell activation involved in immune response (GO:0002275) | 3.01700199 |
| 114 | tryptophan catabolic process (GO:0006569) | 3.01318950 |
| 115 | indole-containing compound catabolic process (GO:0042436) | 3.01318950 |
| 116 | indolalkylamine catabolic process (GO:0046218) | 3.01318950 |
| 117 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00610669 |
| 118 | regulation of sterol transport (GO:0032371) | 2.99351235 |
| 119 | regulation of cholesterol transport (GO:0032374) | 2.99351235 |
| 120 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.98514597 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98130083 |
| 122 | adhesion of symbiont to host cell (GO:0044650) | 2.97975880 |
| 123 | virion attachment to host cell (GO:0019062) | 2.97975880 |
| 124 | regulation of mononuclear cell migration (GO:0071675) | 2.97759866 |
| 125 | membrane lipid catabolic process (GO:0046466) | 2.95997215 |
| 126 | regulation of mast cell activation (GO:0033003) | 2.95300576 |
| 127 | regulation of interferon-alpha production (GO:0032647) | 2.94452245 |
| 128 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94168982 |
| 129 | positive regulation of heat generation (GO:0031652) | 2.92540290 |
| 130 | microglial cell activation (GO:0001774) | 2.92483792 |
| 131 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92390699 |
| 132 | negative regulation of protein activation cascade (GO:2000258) | 2.91855008 |
| 133 | regulation of germinal center formation (GO:0002634) | 2.91453292 |
| 134 | regulation of antigen processing and presentation (GO:0002577) | 2.91171821 |
| 135 | regulation of chemokine biosynthetic process (GO:0045073) | 2.90372088 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 2.89801785 |
| 137 | neutrophil activation (GO:0042119) | 2.89579039 |
| 138 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.88867053 |
| 139 | barbed-end actin filament capping (GO:0051016) | 2.88702132 |
| 140 | modulation by symbiont of host immune response (GO:0052553) | 2.88478197 |
| 141 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88478197 |
| 142 | modulation by symbiont of host defense response (GO:0052031) | 2.88478197 |
| 143 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88478197 |
| 144 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88478197 |
| 145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88478197 |
| 146 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87267926 |
| 147 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86763745 |
| 148 | detection of bacterium (GO:0016045) | 2.86530233 |
| 149 | phospholipid homeostasis (GO:0055091) | 2.85900269 |
| 150 | detection of biotic stimulus (GO:0009595) | 2.85761892 |
| 151 | low-density lipoprotein particle clearance (GO:0034383) | 2.85657737 |
| 152 | low-density lipoprotein particle remodeling (GO:0034374) | 2.84237920 |
| 153 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.84043958 |
| 154 | L-phenylalanine metabolic process (GO:0006558) | 2.84043958 |
| 155 | response to muramyl dipeptide (GO:0032495) | 2.83994883 |
| 156 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.83125475 |
| 157 | NIK/NF-kappaB signaling (GO:0038061) | 2.82795662 |
| 158 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81719225 |
| 159 | nitrogen cycle metabolic process (GO:0071941) | 2.81049289 |
| 160 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.80719302 |
| 161 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.79919203 |
| 162 | cellular response to lipopolysaccharide (GO:0071222) | 2.79579892 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.79545157 |
| 164 | macrophage differentiation (GO:0030225) | 2.79255602 |
| 165 | eosinophil migration (GO:0072677) | 2.78841364 |
| 166 | sphingolipid catabolic process (GO:0030149) | 2.78650385 |
| 167 | response to thyroid hormone (GO:0097066) | 2.78565033 |
| 168 | tryptophan metabolic process (GO:0006568) | 2.78353386 |
| 169 | myeloid dendritic cell activation (GO:0001773) | 2.77437560 |
| 170 | cellular response to molecule of bacterial origin (GO:0071219) | 2.75341204 |
| 171 | positive regulation of type 2 immune response (GO:0002830) | 2.73842702 |
| 172 | defense response to protozoan (GO:0042832) | 2.72472630 |
| 173 | regulation of interleukin-12 production (GO:0032655) | 2.71739913 |
| 174 | response to host immune response (GO:0052572) | 2.70762679 |
| 175 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70762679 |
| 176 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.70171541 |
| 177 | regulation of T cell tolerance induction (GO:0002664) | 2.69805066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.38393096 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32490900 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.08488172 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.97207884 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.93171975 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80270008 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.76899232 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63410461 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.48461849 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.45348946 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.21825373 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.09298087 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.95253624 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88937522 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.66812389 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53127529 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.43069922 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36671052 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36017722 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34196075 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.29718214 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.28088019 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.24699933 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24007715 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.19227891 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08936928 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.00413475 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.95705845 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95105913 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94629369 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94282648 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90096366 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86881653 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.83912838 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78038339 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77262205 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75360701 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72182942 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71674068 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70843511 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69254692 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68941797 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67462271 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60601464 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55242047 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50053905 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47274608 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40427915 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39489306 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38552570 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37079604 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36726751 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35049145 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31579767 |
| 55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31481515 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31103285 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.29525702 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25369027 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22299994 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21807969 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21523863 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21330000 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19718779 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18427762 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18254946 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16395071 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15593961 |
| 68 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.12503945 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.11924836 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11393423 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11384292 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10810006 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10054805 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09470258 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08384993 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06975630 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05397390 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01803688 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01705627 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01135150 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00801216 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99907282 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99367407 |
| 84 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.97679504 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94239560 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93902498 |
| 87 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92710764 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92233732 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92060201 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91973799 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91317182 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91083322 |
| 93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89865601 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89734338 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89592389 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89296063 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89296063 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88296175 |
| 99 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88214705 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87813806 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87222739 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86949201 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86736309 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86057037 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85707753 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85563668 |
| 107 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84262955 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83552886 |
| 109 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83104425 |
| 110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82603504 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82533565 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82116663 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81798766 |
| 114 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81584011 |
| 115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80518293 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80249467 |
| 117 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79931921 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79310106 |
| 119 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78227900 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 0.77707999 |
| 121 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76678697 |
| 122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75858972 |
| 123 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75639832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.41077484 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.83462806 |
| 3 | MP0005365_abnormal_bile_salt | 3.47130838 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.94948934 |
| 5 | MP0003436_decreased_susceptibility_to | 2.94653887 |
| 6 | MP0009840_abnormal_foam_cell | 2.94351333 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.86739492 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.83070167 |
| 9 | MP0005360_urolithiasis | 2.75061462 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.60779768 |
| 11 | MP0003724_increased_susceptibility_to | 2.50612120 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.45102430 |
| 13 | MP0000604_amyloidosis | 2.42636934 |
| 14 | MP0001853_heart_inflammation | 2.41879420 |
| 15 | MP0002419_abnormal_innate_immunity | 2.40333201 |
| 16 | MP0000685_abnormal_immune_system | 2.37805397 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.36514168 |
| 18 | MP0005670_abnormal_white_adipose | 2.17610222 |
| 19 | MP0009278_abnormal_bone_marrow | 2.06861025 |
| 20 | MP0003690_abnormal_glial_cell | 1.96886191 |
| 21 | MP0005025_abnormal_response_to | 1.92682688 |
| 22 | MP0001800_abnormal_humoral_immune | 1.89852936 |
| 23 | MP0003303_peritoneal_inflammation | 1.89445960 |
| 24 | MP0003329_amyloid_beta_deposits | 1.86496026 |
| 25 | MP0001790_abnormal_immune_system | 1.86333800 |
| 26 | MP0005387_immune_system_phenotype | 1.86333800 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.83782025 |
| 28 | MP0005671_abnormal_response_to | 1.82167379 |
| 29 | MP0003828_pulmonary_edema | 1.80933252 |
| 30 | MP0000609_abnormal_liver_physiology | 1.79842536 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.79686138 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.77807154 |
| 33 | MP0009785_altered_susceptibility_to | 1.77055990 |
| 34 | MP0002254_reproductive_system_inflammat | 1.76704305 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.73375566 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.66295500 |
| 37 | MP0008469_abnormal_protein_level | 1.62463576 |
| 38 | MP0000343_altered_response_to | 1.60207914 |
| 39 | MP0008004_abnormal_stomach_pH | 1.51867359 |
| 40 | MP0003448_altered_tumor_morphology | 1.51421826 |
| 41 | MP0003075_altered_response_to | 1.50930940 |
| 42 | MP0005451_abnormal_body_composition | 1.50305617 |
| 43 | MP0003252_abnormal_bile_duct | 1.49256081 |
| 44 | MP0002723_abnormal_immune_serum | 1.48281256 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.46288913 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.44984956 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.44588489 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.42978240 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.40440645 |
| 50 | MP0001727_abnormal_embryo_implantation | 1.36064799 |
| 51 | MP0006054_spinal_hemorrhage | 1.34901741 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.33056537 |
| 53 | MP0001819_abnormal_immune_cell | 1.32486233 |
| 54 | MP0000858_altered_metastatic_potential | 1.31266659 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.30000609 |
| 56 | MP0002405_respiratory_system_inflammati | 1.29425032 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.28776913 |
| 58 | MP0009763_increased_sensitivity_to | 1.23146482 |
| 59 | MP0005332_abnormal_amino_acid | 1.22489535 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.22044134 |
| 61 | MP0004130_abnormal_muscle_cell | 1.19131695 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.19000245 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.15635808 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.15458444 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.15337522 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.10152715 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.08974156 |
| 68 | MP0008260_abnormal_autophagy | 1.07485049 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06108691 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.05338523 |
| 71 | MP0005083_abnormal_biliary_tract | 1.03696922 |
| 72 | MP0005666_abnormal_adipose_tissue | 1.01412098 |
| 73 | MP0001666_abnormal_nutrient_absorption | 0.98951299 |
| 74 | MP0004510_myositis | 0.97644180 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.97186537 |
| 76 | MP0005334_abnormal_fat_pad | 0.97059039 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.96264473 |
| 78 | MP0009764_decreased_sensitivity_to | 0.94357925 |
| 79 | MP0002166_altered_tumor_susceptibility | 0.93722183 |
| 80 | MP0005647_abnormal_sex_gland | 0.93633589 |
| 81 | MP0005166_decreased_susceptibility_to | 0.92793610 |
| 82 | MP0003279_aneurysm | 0.92229061 |
| 83 | MP0001542_abnormal_bone_strength | 0.90617851 |
| 84 | MP0000249_abnormal_blood_vessel | 0.88809316 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.88561754 |
| 86 | MP0005165_increased_susceptibility_to | 0.87589845 |
| 87 | MP0000598_abnormal_liver_morphology | 0.87248393 |
| 88 | MP0005275_abnormal_skin_tensile | 0.87185970 |
| 89 | MP0001764_abnormal_homeostasis | 0.86068078 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.84398567 |
| 91 | MP0000689_abnormal_spleen_morphology | 0.84276198 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.84197803 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.81804579 |
| 94 | MP0003795_abnormal_bone_structure | 0.80653585 |
| 95 | MP0002295_abnormal_pulmonary_circulatio | 0.80425305 |
| 96 | MP0000716_abnormal_immune_system | 0.79590443 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.79218382 |
| 98 | MP0003045_fibrosis | 0.79189540 |
| 99 | MP0005164_abnormal_response_to | 0.79152407 |
| 100 | MP0000920_abnormal_myelination | 0.77696268 |
| 101 | MP0003195_calcinosis | 0.77614447 |
| 102 | MP0009642_abnormal_blood_homeostasis | 0.76893079 |
| 103 | MP0004947_skin_inflammation | 0.76831966 |
| 104 | MP0005310_abnormal_salivary_gland | 0.76413790 |
| 105 | MP0003091_abnormal_cell_migration | 0.75837404 |
| 106 | MP0004883_abnormal_blood_vessel | 0.75029390 |
| 107 | MP0006082_CNS_inflammation | 0.73166466 |
| 108 | MP0002933_joint_inflammation | 0.72455255 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.72447227 |
| 110 | MP0002398_abnormal_bone_marrow | 0.72294979 |
| 111 | MP0002060_abnormal_skin_morphology | 0.71720369 |
| 112 | MP0003632_abnormal_nervous_system | 0.71662487 |
| 113 | MP0001663_abnormal_digestive_system | 0.71110296 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.70782606 |
| 115 | MP0005535_abnormal_body_temperature | 0.70681852 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.70524203 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.70524203 |
| 118 | MP0005023_abnormal_wound_healing | 0.69358623 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.68947799 |
| 120 | MP0000465_gastrointestinal_hemorrhage | 0.68784067 |
| 121 | MP0005390_skeleton_phenotype | 0.68124754 |
| 122 | MP0003186_abnormal_redox_activity | 0.67994373 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.67967619 |
| 124 | MP0008874_decreased_physiological_sensi | 0.67263355 |
| 125 | MP0002722_abnormal_immune_system | 0.67054575 |
| 126 | MP0003634_abnormal_glial_cell | 0.66576114 |
| 127 | MP0002090_abnormal_vision | 0.65848139 |
| 128 | MP0002429_abnormal_blood_cell | 0.65779212 |
| 129 | MP0001851_eye_inflammation | 0.65254177 |
| 130 | MP0003633_abnormal_nervous_system | 0.61109503 |
| 131 | MP0000371_diluted_coat_color | 0.58027643 |
| 132 | MP0005257_abnormal_intraocular_pressure | 0.55819170 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.55792428 |
| 134 | MP0010307_abnormal_tumor_latency | 0.54590434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 8.20405184 |
| 2 | Glomerulonephritis (HP:0000099) | 8.02837841 |
| 3 | Abnormality of complement system (HP:0005339) | 7.40902768 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.25731890 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.14331170 |
| 6 | Nephritis (HP:0000123) | 4.67413089 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.57710991 |
| 8 | Disinhibition (HP:0000734) | 4.54230057 |
| 9 | Mutism (HP:0002300) | 4.40099276 |
| 10 | Loss of speech (HP:0002371) | 4.32914341 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.32850875 |
| 12 | Joint hemorrhage (HP:0005261) | 4.32018984 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.25709365 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.18163779 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.99070004 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.86626440 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.86626440 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.86626440 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.67791844 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.63239818 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.63239818 |
| 22 | Orchitis (HP:0100796) | 3.62393121 |
| 23 | Xanthomatosis (HP:0000991) | 3.54708177 |
| 24 | Thick nail (HP:0001805) | 3.54444849 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.53971738 |
| 26 | Myocardial infarction (HP:0001658) | 3.53198535 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.53125331 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.53069725 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.43138078 |
| 30 | Optic neuritis (HP:0100653) | 3.43138078 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.25116049 |
| 32 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.20576012 |
| 33 | Deep venous thrombosis (HP:0002625) | 3.18987508 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.18694051 |
| 35 | Nuclear cataract (HP:0100018) | 3.17049884 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 3.13746636 |
| 37 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.13746636 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 3.04727511 |
| 39 | Stomatitis (HP:0010280) | 3.04021081 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 3.02473883 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.91126693 |
| 42 | Axonal loss (HP:0003447) | 2.83995573 |
| 43 | Recurrent skin infections (HP:0001581) | 2.82589378 |
| 44 | Gingivitis (HP:0000230) | 2.81594163 |
| 45 | Increased serum ferritin (HP:0003281) | 2.77501535 |
| 46 | Cellulitis (HP:0100658) | 2.74416834 |
| 47 | Petechiae (HP:0000967) | 2.73132647 |
| 48 | Amyloidosis (HP:0011034) | 2.69597203 |
| 49 | Pustule (HP:0200039) | 2.69362844 |
| 50 | Neuronal loss in central nervous system (HP:0002529) | 2.66841016 |
| 51 | Apathy (HP:0000741) | 2.65388175 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.63626815 |
| 53 | Diminished motivation (HP:0000745) | 2.63529961 |
| 54 | Inappropriate behavior (HP:0000719) | 2.60946182 |
| 55 | Progressive visual loss (HP:0000529) | 2.60427442 |
| 56 | Agnosia (HP:0010524) | 2.58879905 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.58654792 |
| 58 | Hypolipoproteinemia (HP:0010981) | 2.53466635 |
| 59 | Intrahepatic cholestasis (HP:0001406) | 2.51359563 |
| 60 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.50743893 |
| 61 | Retinal atrophy (HP:0001105) | 2.48682989 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.48135418 |
| 63 | Colitis (HP:0002583) | 2.46681863 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.44303316 |
| 65 | Mitral stenosis (HP:0001718) | 2.42326999 |
| 66 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.39929761 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.38161108 |
| 68 | Periodontitis (HP:0000704) | 2.37377927 |
| 69 | Skin nodule (HP:0200036) | 2.37315639 |
| 70 | Hemoptysis (HP:0002105) | 2.36128188 |
| 71 | Prostate neoplasm (HP:0100787) | 2.35014680 |
| 72 | Metaphyseal irregularity (HP:0003025) | 2.33417288 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 2.31101830 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.29933592 |
| 75 | Epidermoid cyst (HP:0200040) | 2.23874167 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.23851690 |
| 77 | Gingival bleeding (HP:0000225) | 2.16874388 |
| 78 | Keratoconjunctivitis (HP:0001096) | 2.15836552 |
| 79 | Polyneuropathy (HP:0001271) | 2.13467914 |
| 80 | Dementia (HP:0000726) | 2.12735996 |
| 81 | Epistaxis (HP:0000421) | 2.12453447 |
| 82 | Hepatosplenomegaly (HP:0001433) | 2.12280067 |
| 83 | Conjunctival telangiectasia (HP:0000524) | 2.11901877 |
| 84 | Hematochezia (HP:0002573) | 2.10899805 |
| 85 | Malnutrition (HP:0004395) | 2.08245233 |
| 86 | Personality changes (HP:0000751) | 2.07133906 |
| 87 | Abnormality of the prostate (HP:0008775) | 2.07038457 |
| 88 | Hypokinesia (HP:0002375) | 2.06959538 |
| 89 | Vasculitis (HP:0002633) | 2.05930623 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.04151040 |
| 91 | Upper motor neuron abnormality (HP:0002127) | 2.03668179 |
| 92 | Purpura (HP:0000979) | 2.02808479 |
| 93 | Alopecia of scalp (HP:0002293) | 2.02722068 |
| 94 | Basal ganglia calcification (HP:0002135) | 2.02378921 |
| 95 | Hyperglycinuria (HP:0003108) | 2.00126889 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 10.4509675 |
| 97 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99373993 |
| 98 | Memory impairment (HP:0002354) | 1.97677180 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96395280 |
| 100 | Hypercholesterolemia (HP:0003124) | 1.95910493 |
| 101 | Abnormality of the periventricular white matter (HP:0002518) | 1.93412386 |
| 102 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.93031244 |
| 103 | Abnormality of glycine metabolism (HP:0010895) | 1.92457952 |
| 104 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92457952 |
| 105 | Pulmonary embolism (HP:0002204) | 1.91874774 |
| 106 | Increased connective tissue (HP:0009025) | 1.91712337 |
| 107 | Dysostosis multiplex (HP:0000943) | 1.90833187 |
| 108 | Hypobetalipoproteinemia (HP:0003563) | 1.89751057 |
| 109 | Abnormality of the peritoneum (HP:0002585) | 1.88954948 |
| 110 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88103380 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87781235 |
| 112 | Peripheral demyelination (HP:0011096) | 1.86009426 |
| 113 | Global brain atrophy (HP:0002283) | 1.85230742 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84134368 |
| 115 | Hypertriglyceridemia (HP:0002155) | 1.83397776 |
| 116 | Supranuclear gaze palsy (HP:0000605) | 1.82777868 |
| 117 | Thoracic kyphosis (HP:0002942) | 1.81378898 |
| 118 | Hyperammonemia (HP:0001987) | 1.81063111 |
| 119 | Increased CSF protein (HP:0002922) | 1.80947414 |
| 120 | Cardiomegaly (HP:0001640) | 1.79908001 |
| 121 | Meningitis (HP:0001287) | 1.78391372 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.77882634 |
| 123 | Abnormality of methionine metabolism (HP:0010901) | 1.76914060 |
| 124 | Bone pain (HP:0002653) | 1.74553249 |
| 125 | T lymphocytopenia (HP:0005403) | 1.74431934 |
| 126 | Prolonged bleeding time (HP:0003010) | 1.73760302 |
| 127 | Vertigo (HP:0002321) | 1.73110652 |
| 128 | Pathologic fracture (HP:0002756) | 1.73013708 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.72962633 |
| 130 | Prolonged neonatal jaundice (HP:0006579) | 1.72692482 |
| 131 | Facial diplegia (HP:0001349) | 1.71636087 |
| 132 | Hyperglycinemia (HP:0002154) | 1.70830185 |
| 133 | Gangrene (HP:0100758) | 1.70779841 |
| 134 | Inflammation of the large intestine (HP:0002037) | 1.70747513 |
| 135 | Progressive inability to walk (HP:0002505) | 1.70088394 |
| 136 | Recurrent fungal infections (HP:0002841) | 1.68736007 |
| 137 | Abnormality of macrophages (HP:0004311) | 1.67731483 |
| 138 | Arterial thrombosis (HP:0004420) | 1.67537336 |
| 139 | Urticaria (HP:0001025) | 1.67465044 |
| 140 | Distal lower limb muscle weakness (HP:0009053) | 1.67028574 |
| 141 | Parakeratosis (HP:0001036) | 1.66971997 |
| 142 | Restrictive lung disease (HP:0002091) | 1.66620524 |
| 143 | Ketosis (HP:0001946) | 1.65179695 |
| 144 | Panhypogammaglobulinemia (HP:0003139) | 1.64518050 |
| 145 | Spinal muscular atrophy (HP:0007269) | 1.64400396 |
| 146 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.64289651 |
| 147 | Recurrent viral infections (HP:0004429) | 1.64205904 |
| 148 | Obstructive lung disease (HP:0006536) | 1.64064079 |
| 149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64064079 |
| 150 | Abnormality of the lumbar spine (HP:0100712) | 1.62293112 |
| 151 | Myositis (HP:0100614) | 1.61992408 |
| 152 | Interstitial pulmonary disease (HP:0006530) | 1.61133540 |
| 153 | Abnormality of glycolipid metabolism (HP:0010969) | 1.60847498 |
| 154 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.60847498 |
| 155 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.60847498 |
| 156 | Hypoglycemic coma (HP:0001325) | 1.58933364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.89967363 |
| 2 | MUSK | 3.48572068 |
| 3 | TYK2 | 3.33248759 |
| 4 | MAP3K14 | 3.30733674 |
| 5 | RIPK4 | 2.76542880 |
| 6 | TGFBR2 | 2.72653361 |
| 7 | NME2 | 2.67884373 |
| 8 | DDR2 | 2.48575907 |
| 9 | IKBKB | 2.46937482 |
| 10 | BTK | 2.28429340 |
| 11 | TAOK3 | 2.25719577 |
| 12 | FGR | 2.20793709 |
| 13 | IRAK4 | 2.19630142 |
| 14 | CAMK1D | 2.12193902 |
| 15 | JAK1 | 2.08346078 |
| 16 | EPHB1 | 2.05764061 |
| 17 | YES1 | 1.95013278 |
| 18 | TAOK2 | 1.93402846 |
| 19 | PRPF4B | 1.89950124 |
| 20 | CSK | 1.87151307 |
| 21 | CSF1R | 1.81146547 |
| 22 | MAP3K11 | 1.80255985 |
| 23 | TBK1 | 1.72065388 |
| 24 | GRK7 | 1.71959126 |
| 25 | TAOK1 | 1.71842833 |
| 26 | ACVR1B | 1.68058501 |
| 27 | ERN1 | 1.55872832 |
| 28 | CDC42BPA | 1.50685033 |
| 29 | TEC | 1.48264517 |
| 30 | HCK | 1.43013796 |
| 31 | IKBKE | 1.41962893 |
| 32 | JAK2 | 1.40699135 |
| 33 | FGFR4 | 1.40570449 |
| 34 | TTN | 1.34915857 |
| 35 | RIPK1 | 1.34316319 |
| 36 | ZAP70 | 1.34199777 |
| 37 | SCYL2 | 1.32876072 |
| 38 | IRAK3 | 1.31641251 |
| 39 | LYN | 1.29276614 |
| 40 | KIT | 1.25089821 |
| 41 | NEK9 | 1.23048012 |
| 42 | EPHA3 | 1.22980139 |
| 43 | CAMK1G | 1.20119472 |
| 44 | BCKDK | 1.17279054 |
| 45 | FES | 1.15631451 |
| 46 | MAPK15 | 1.15503755 |
| 47 | SIK1 | 1.13539817 |
| 48 | MAP4K1 | 1.13197013 |
| 49 | PIK3CG | 1.06106583 |
| 50 | CDK6 | 1.05366080 |
| 51 | MAP3K1 | 1.05183427 |
| 52 | PTK6 | 1.00002055 |
| 53 | PIM2 | 0.99215471 |
| 54 | LCK | 0.94971945 |
| 55 | CLK1 | 0.94052731 |
| 56 | PDGFRB | 0.93554399 |
| 57 | MAP2K3 | 0.93415726 |
| 58 | TRIB3 | 0.92126636 |
| 59 | FGFR3 | 0.91980077 |
| 60 | SYK | 0.90609580 |
| 61 | CHUK | 0.86679372 |
| 62 | ITK | 0.86473326 |
| 63 | MAP2K2 | 0.85407482 |
| 64 | IRAK2 | 0.82685573 |
| 65 | TGFBR1 | 0.82533545 |
| 66 | DAPK2 | 0.79027150 |
| 67 | MARK3 | 0.77088151 |
| 68 | TRPM7 | 0.75592351 |
| 69 | MAP3K5 | 0.75560868 |
| 70 | PRKAA2 | 0.74969576 |
| 71 | EIF2AK2 | 0.72760748 |
| 72 | MAPK12 | 0.70675176 |
| 73 | TNK2 | 0.70574447 |
| 74 | ADRBK2 | 0.69736206 |
| 75 | CAMKK1 | 0.69080075 |
| 76 | ABL2 | 0.69036815 |
| 77 | FLT3 | 0.67914926 |
| 78 | STK10 | 0.66899254 |
| 79 | INSRR | 0.63367322 |
| 80 | TESK2 | 0.62823903 |
| 81 | MAP2K6 | 0.62242475 |
| 82 | GSK3A | 0.61575502 |
| 83 | PDK2 | 0.60297365 |
| 84 | PDPK1 | 0.60291782 |
| 85 | MAPK4 | 0.59544506 |
| 86 | PKN2 | 0.59530603 |
| 87 | CAMKK2 | 0.59331901 |
| 88 | JAK3 | 0.59315774 |
| 89 | FRK | 0.59111472 |
| 90 | MATK | 0.58641120 |
| 91 | MST4 | 0.58306063 |
| 92 | TYRO3 | 0.55809624 |
| 93 | PKN1 | 0.54895305 |
| 94 | NUAK1 | 0.52823690 |
| 95 | EGFR | 0.51324779 |
| 96 | RPS6KL1 | 0.51230432 |
| 97 | RPS6KC1 | 0.51230432 |
| 98 | MAP3K3 | 0.51204318 |
| 99 | DMPK | 0.51056052 |
| 100 | PDGFRA | 0.51039992 |
| 101 | MOS | 0.50922210 |
| 102 | SIK3 | 0.49995388 |
| 103 | PDK1 | 0.49702726 |
| 104 | TXK | 0.49358093 |
| 105 | MAPKAPK2 | 0.49272933 |
| 106 | TESK1 | 0.49118413 |
| 107 | SGK1 | 0.47817897 |
| 108 | MAPK7 | 0.47552307 |
| 109 | IGF1R | 0.47002792 |
| 110 | ROCK1 | 0.45027600 |
| 111 | EPHB2 | 0.42451657 |
| 112 | RPS6KA6 | 0.41677767 |
| 113 | RPS6KA2 | 0.41463649 |
| 114 | PRKCD | 0.41183405 |
| 115 | BMPR2 | 0.40955286 |
| 116 | ARAF | 0.40631343 |
| 117 | MAPK11 | 0.39387760 |
| 118 | PAK4 | 0.39150214 |
| 119 | MARK2 | 0.38669591 |
| 120 | FYN | 0.38249330 |
| 121 | PAK2 | 0.37253459 |
| 122 | MST1R | 0.36173513 |
| 123 | ABL1 | 0.35676636 |
| 124 | HIPK2 | 0.34785993 |
| 125 | MAP3K6 | 0.31080891 |
| 126 | MAP3K13 | 0.30354585 |
| 127 | PIM1 | 0.28249476 |
| 128 | PRKACG | 0.27765029 |
| 129 | INSR | 0.27568476 |
| 130 | MAPK3 | 0.26244202 |
| 131 | PRKACB | 0.26222595 |
| 132 | SRC | 0.26023304 |
| 133 | PRKG1 | 0.25633567 |
| 134 | KSR2 | 0.25177904 |
| 135 | SGK3 | 0.24816878 |
| 136 | PRKG2 | 0.24595840 |
| 137 | IRAK1 | 0.23947798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.40668087 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.09359167 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11328057 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.02075826 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.75044504 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.60540097 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.43022904 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.32274871 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18505142 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05798587 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.04956732 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.03028478 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.00894179 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95392708 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88043739 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.87025924 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.83266036 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77904197 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67488742 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66229404 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.65241528 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63187837 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60406955 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.58915301 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58525160 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52001112 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46208518 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45908730 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44767829 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.43660600 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.42656634 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.38400830 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37443917 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36728007 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.32924951 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32477590 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28054882 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.25884558 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23582131 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21515171 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18719386 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17156025 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16516352 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14386754 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10979151 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10687314 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09692334 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09081430 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08788242 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 1.08199644 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.05377839 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03254895 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02861229 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01456923 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99181016 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98161918 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.96215916 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90605397 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90444038 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89502547 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87412540 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85980229 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85201292 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85033549 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.84784387 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83657823 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82790677 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.81823542 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81216847 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80826062 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78065414 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76197166 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.74460166 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.72638466 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72605026 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.71575182 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.69067248 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67245653 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66146477 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.65206049 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63775220 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63693891 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63649019 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63429251 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.62943677 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.61554315 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60534887 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60463136 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.59375896 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.59212001 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58035516 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57349517 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56703243 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.56262133 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54968253 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54194822 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53123948 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52805477 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52265904 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52104676 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49947426 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49822506 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49707825 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49396393 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.48724205 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48711500 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47849585 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47056307 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46733080 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46443240 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45269411 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44116379 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42358197 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42010548 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39974444 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.39956061 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38539205 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38137211 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36270769 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36203914 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36120670 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.35048451 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34961706 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34637670 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34362032 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33485788 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32597058 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32515520 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.31849859 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29670597 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28604434 |
| 132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28432515 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27995101 |
| 134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.27940403 |
| 135 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27769866 |
| 136 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27041109 |
| 137 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26957434 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.25485259 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25189759 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25140370 |
| 141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22435193 |
| 142 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.22070931 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21361237 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20514580 |
| 145 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20464041 |
| 146 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19832272 |
| 147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18151804 |
| 148 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.15437844 |
| 149 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.12529156 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11770533 |

